DIVE Medical develops a digital medical device that utilizes eye tracking and artificial intelligence to conduct fast and accurate visual function assessments in non-verbal patients, starting from six months of age. This technology provides objective metrics for detecting various ocular pathologies, enhancing decision-making in pediatric and low-vision care.
Funding
$1.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for assessing visual function in non-verbal patients, especially young children, often rely on subjective observations and may lack the precision needed for early and accurate diagnosis of ocular pathologies. Traditional visual function tests can be difficult to administer in patients with cognitive or neurological difficulties, leading to delayed diagnoses and potentially impacting treatment outcomes.
Solution
DIVE Medical offers a digital medical device that uses eye-tracking technology and artificial intelligence to provide fast and objective visual function assessments in patients as young as six months old, including those who are non-verbal or have cognitive challenges. The device captures comprehensive data on various visual functions, generating objective metrics that aid in the detection of refractive disorders, amblyopia, strabismus, and other ocular conditions. By automating the testing process and reducing reliance on subjective interpretation, DIVE Medical's technology enhances decision-making in pediatric and low-vision care, enabling earlier intervention and improved patient outcomes. The system's portability and child-friendly design facilitate testing in various clinical settings.
Target Audience
The primary target audience includes pediatric ophthalmologists, optometrists specializing in low vision, and clinical researchers focused on early detection and management of visual disorders in children and patients with communication difficulties.
Features
- Eye-tracking technology for precise measurement of visual function
- AI-powered algorithms for automated data analysis and objective metric generation
- Comprehensive assessment of refractive disorders, amblyopia, strabismus, and other ocular pathologies
- Suitable for patients from six months of age, including non-verbal and cognitively challenged individuals
- Portable and child-friendly design for easy use in various clinical settings
- Objective and measurable data to support clinical decision-making and treatment monitoring